Johnson & Johnson

CILAG AG

Featured products of Cilag AG
daratumumab
Packing/Price
20 mL x 1's5 mL x 1's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01FC01 - daratumumab : Belongs to the class of CD38 (Clusters of Differentiation 38) inhibitors. Used in the treatment of cancer.
guselkumab
Packing/Price
1's
MIMS Class
Immunosuppressants, Psoriasis, Seborrhea & Ichthyosis Preparations
ATC Classification
L04AC16 - guselkumab : Belongs to the class of interleukin inhibitors. Used as immunosuppressants.
Distributed by Johnson & Johnson
daratumumab
Packing/Price
20 mL x 1's5 mL x 1's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01FC01 - daratumumab : Belongs to the class of CD38 (Clusters of Differentiation 38) inhibitors. Used in the treatment of cancer.
guselkumab
Packing/Price
1's
MIMS Class
Immunosuppressants, Psoriasis, Seborrhea & Ichthyosis Preparations
ATC Classification
L04AC16 - guselkumab : Belongs to the class of interleukin inhibitors. Used as immunosuppressants.

Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in